| review article | Q7318358 |
| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1017119005 |
| P356 | DOI | 10.2165/00003495-197816050-00002 |
| P8608 | Fatcat ID | release_umtr2undyfdybgponxheyxlpf4 |
| P698 | PubMed publication ID | 363399 |
| P50 | author | Rex N. Brogden | Q62563651 |
| P2093 | author name string | G S Avery | |
| R C Heel | |||
| T M Speight | |||
| P2860 | cites work | Metronidazole for Crohn's disease | Q28317693 |
| Pharmacokinetics of tinidazole and metronidazole in women after single large oral doses | Q33654651 | ||
| Further observations on metronidazole (Flagyl). | Q33663411 | ||
| Metronidazole in human infections with syphilis | Q33664902 | ||
| The antibacterial activity of metronidazole | Q34079925 | ||
| The bactericidal activity of nitrofurantoin and metronidazole against anaerobic bacteria | Q34471676 | ||
| Anaerobic infection in a neonate. Early detection by gas liquid chromatography and response to metronidazole | Q34985813 | ||
| Antimicrobial susceptibilities of anaerobic bacteria: recent clinical isolates | Q35656719 | ||
| Absence of Strand Breaks in Deoxyribonucleic Acid Treated with Metronidazole | Q36465236 | ||
| Metronidazole versus anaerobes. In vitro data and initial clinical observations | Q36523211 | ||
| A comparison of the in vitro activity of metronidazole, tinidazole, and nimorazole against Gram-negative anaerobic bacilli | Q36593247 | ||
| Comparison of two commercially available media for detection of bacteremia | Q37148874 | ||
| Comparative Pharmacokinetic Studies of Ornidazole and Metronidazole in Man | Q67438558 | ||
| Metronidazole in prevention and treatment of bacteroides infections after appendicectomy | Q67472039 | ||
| Anaerobic bacteria in chronic otitis media | Q67569380 | ||
| Metronidazole in anaerobic infections | Q67572526 | ||
| Treatment with metronidazole of 48 patients with serious anaerobic infections | Q67655856 | ||
| Quantitative bacteriology of the vaginal flora | Q67656917 | ||
| Interaction of metronidazole with nucleic acids in vitro | Q67660084 | ||
| Pharmacokinetics of metronidazole during short-term therapy of trichomoniasis urogenitalis | Q67705552 | ||
| The stereoselective interaction of warfarin and metronidazole in man | Q67745717 | ||
| Anaerobic meningitis and bacteremia caused by Fusobacterium species | Q67763377 | ||
| Effect of tinidazole, metronidazole and nitrofurazone on nucleic acid synthesis in Clostridium bifermentans | Q67789390 | ||
| Metronidazole and anaerobic sepsis | Q68230206 | ||
| Activity of metronidazole against experimental tetanus and gas gangrene | Q68587592 | ||
| The mode of action of metronidazole in Trichomonas vaginalis and other micro-organisms | Q68685745 | ||
| The effect of metronidazole on the experimental mixed infection of oral anaerobes | Q69013261 | ||
| Carcinogenicity of 5-nitrofurans, 5-nitroimidazoles, 4-nitrobenzenes, and related compounds | Q69034594 | ||
| The selective toxicity of antimicrobial nitroheterocyclic drugs | Q69114674 | ||
| Bacteriology and treatment of primary lung abscess | Q69340935 | ||
| The pharmacokinetics of metronidazole and tinidazole in man | Q69462851 | ||
| Bactericidal Activity of Five Antimicrobial Agents against Bacteroides fragilis | Q70404015 | ||
| Effect of metronidazole on hydrogen production by Clostridium acetobutylicum | Q70434784 | ||
| Induction of lung tumors and malignant lymphomas in mice by metronidazole | Q70448786 | ||
| Anaerobic bacteremia | Q70483866 | ||
| Anaerobic bacterial endocarditis | Q71576432 | ||
| The isolation and identification of the urinary oxidative metabolites of metronidazole in man | Q72132852 | ||
| Penetration of Cephalothin and Lincomycin into the Cerebrospinal Fluid | Q72337480 | ||
| Disulfiram-metronidazole | Q72408021 | ||
| The Peripheral White Blood Cells and Metronidazole | Q72742728 | ||
| Bacteroides fragilis endocarditis, bacteremia and other infections treated with oral or intravenous metronidazole | Q45261698 | ||
| Bacteriological study of otogenic cerebral abscesses: chemotherapeutic role of metronidazole | Q48257300 | ||
| Bacteroides fragilis ventriculitis and meningitis. Report of two cases | Q48373605 | ||
| Letter: Treatment of a brain abscess due to Bacteroides fragilis with metronidazole | Q48400697 | ||
| Treatment with metronidazole of three patients with serious infections due to Bacteroides fragilis | Q48458260 | ||
| Toxicity of Disulfiram Combined with Metronidazole | Q53774919 | ||
| Blood levels of chemotherapeutic drugs and the pharmacokinetics of tinidazole and metronidazole. | Q54130957 | ||
| Anaerobic Bacterial Infections of the Female Genital Tract | Q54133629 | ||
| Bacteroides fragilis resistant to metronidazole after long-term therapy. | Q54588370 | ||
| The bacteriology of aspiration pneumonia | Q54591610 | ||
| Successful treatment of Bacteroides bacteraemia with metronidazole, after failure with clindamycin and lincomycin. | Q54597640 | ||
| Susceptibility of Anaerobic bacteria to carbenicillin, cefoxitin, and related drugs. | Q54627673 | ||
| Anaerobic septicemia from thrombophlebitis of the internal jugular vein. Successful treatment with metronidazole. | Q54632935 | ||
| Biochemical Characterization and in vitro Determination of Antibiotic Susceptibility of Clinical Isolates of Bacteroides fragilis | Q54643598 | ||
| Metronidazole in prevention and treatment of bacteroides infections in elective colonic surgery | Q55339286 | ||
| Letter: Metronidazole in treatment of empyema | Q55380503 | ||
| Fusobacterium endocarditis treated with metronidazole | Q55692885 | ||
| Mismanaged facial infection | Q66696114 | ||
| Treatment of anaerobically infected pressure sores with topical metronidazole | Q66697539 | ||
| Will the real Clostridium species responsible for antibiotic-associated colitis please step forward? | Q66697788 | ||
| Letter: Drug treatment in Crohn's disease | Q66702815 | ||
| Treatment of purulent anaerobic pleurisy by local injections of metronidazole | Q66847352 | ||
| An evaluation of metronidazole in the prophylaxis and treatment of anaerobic infections in surgical patients | Q66904863 | ||
| Bactericidal activity of metronidazole, tinidazole and ornidazole against Bacteroides fragilis in vitro | Q67053531 | ||
| Identification of Clostridium difficile as a cause of pseudomembranous colitis | Q67288099 | ||
| Bioassay of Metronidazole with Either Anaerobic or Aerobic Incubation | Q67326056 | ||
| Metronidazole treatment of liver abscess due to bacteroides fragilis | Q67361357 | ||
| Activity-electroreduction relationship of antimicrobial metronidazole analogs | Q39192525 | ||
| Prophylactic oral antimicrobial agents in elective colonic surgery. A controlled trial | Q39355829 | ||
| Bacteroides: an unusual cause of breast abscess | Q39387983 | ||
| Metronidazole and acne | Q39393494 | ||
| Prophylactic systemic antibiotics in colorectal surgery | Q39442335 | ||
| What are Anaerobic Cocci? | Q39458509 | ||
| Inhibition of phagocytosis in vitro by obligate anaerobes | Q39468353 | ||
| The antimicrobial effect of combinations of clindamycin and metronidazole with spectinomycinn | Q39754406 | ||
| Assessment of the in vitro activity against Bacteroides spp. of spectinomycin, metronidazole and clindamycin | Q39824858 | ||
| Fixed Drug Eruption Due to Metronidazole | Q39831524 | ||
| Susceptibility of Anaerobic Bacteria to Metronidazole: Relative Resistance of Non-Spore-Forming Gram-Positive Baccilli | Q39921480 | ||
| Infective endocarditis—1973 | Q39938233 | ||
| Antibiotic Susceptibility Testing of Anaerobic Bacteria by the Standardized Disc Diffusion Method with Special Reference to Bacteroides fragilis | Q39939580 | ||
| Anaerobic infections: a review | Q39940660 | ||
| Antibiotic Susceptibility of Clostridium Species Isolated from Human Infections | Q39954552 | ||
| Metronidazole: view of uses and toxicity | Q40062362 | ||
| Antimicrobial activity of metronidazole in anaerobic bacteria | Q40301840 | ||
| Susceptibility of Campylobacter fetus to twenty-two antimicrobial agents | Q40471086 | ||
| Susceptibility of anaerobic bacteria to metronidazole, ornidazole, and tinidazole and routine susceptibility testing by standardized methods | Q40617130 | ||
| Use of High-Pressure Liquid Chromatography to Determine Plasma Levels of Metronidazole and Metabolites After Intravenous Administration | Q40617971 | ||
| Nonspecific vaginitis: role of Haemophilus vaginalis and treatment with metronidazole | Q40677662 | ||
| The Anaerobic Culture of Clinical Specimens: A 14-Month Study | Q40751708 | ||
| Metronidazole compared with penicillin in the treatment of acute dental infections | Q40755013 | ||
| Improving the performance of anaerobic bacteriology in a hospital laboratory | Q40757420 | ||
| Bioavailability of metronidazole in fasting and non-fasting healthy subjects and in patients with Crohn's disease | Q40809592 | ||
| The effect of metronidazole on the incidence of postoperative wound infection in elective colon surgery | Q40855001 | ||
| Protective effect of metronidazole in experimentalulcerative colitis | Q40866948 | ||
| Phase II study of metronidazole therapy for advanced colorectal carcinoma | Q40887378 | ||
| Pharmacokinetics and therapeutic efficacy of metronidazole at different dosages | Q40933462 | ||
| Microbiological agar diffusion assay for metronidazole concentrations in serum | Q40943242 | ||
| Susceptibility of Clostridium ramosum to antimicrobial agents | Q40943384 | ||
| Treatment of anaerobic infections with metronidazole | Q40944352 | ||
| In vitro activity of josamycin and rosamicin against Bacteroides fragilis compared with clindamycin, erythromycin, and metronidazole | Q40946961 | ||
| Susceptibility of anaerobic bacteria to 23 antimicrobial agents | Q40947577 | ||
| Pharmacokinetics of metronidazole as determined by bioassay | Q41031006 | ||
| The Fate of Metronidazole and its Implications in Chemotherapy | Q41070401 | ||
| Metronidazole in the treatment of severe acute pericoronitis. A clinical trail | Q41246178 | ||
| Bactericidal activity of metronidazole against Bacteroides fragilis | Q41261523 | ||
| Prophylactic antibiotics in bowel surgery | Q42155736 | ||
| The Use of Metronidazole in the Preparation of the Bowel for Surgery | Q42704454 | ||
| Bacteriology of empyema | Q43461557 | ||
| An investigation of interactions between metronidazole (“Flagyl”) and other antibacterial agents | Q43500428 | ||
| The bioavailability of commercial metronidazole formulations | Q43512898 | ||
| A study of carbon dioxide-dependent strains of Streptococcus milleri | Q43747237 | ||
| A significant interaction between metronidazole and warfarin | Q43951690 | ||
| Intra-abdominal abscesses | Q43977746 | ||
| The spectrum of antibacterial activity of metronidazole | Q43988870 | ||
| Chemical reduction of the compulsion to drink with metronidazole: a new treatment modality in the therapeutic program of the alcoholic. | Q44061532 | ||
| Excretion of metroindazole in human bile. Investigations of hepatic bile, common duct bile, and gallbladder bile | Q44155618 | ||
| Bacteroides fragilis meningitis | Q44293020 | ||
| Activity of Combinations of Antimicrobial Agents against Bacteroides fragilis | Q44296384 | ||
| The action of metronidazole on DNA | Q44570592 | ||
| A new approach to patients with suspected anaerobic postpartum pelvic infections. Transabdominal uterine aspiration for culture and metronidazole for treatment | Q44774800 | ||
| Letter: Value of metronidazole in septicemia caused by Bacteroides fragilis. 2 cases | Q44931734 | ||
| Metronidazole-spiramycin combination. In situ concentrations and synergism compared with the minimal inhibitory concentration of the buccal flora | Q44959513 | ||
| P433 | issue | 5 | |
| P921 | main subject | metronidazole | Q169569 |
| pharmacokinetics | Q323936 | ||
| P304 | page(s) | 387-417 | |
| P577 | publication date | 1978-11-01 | |
| P1433 | published in | Drugs | Q3040094 |
| P1476 | title | Metronidazole in anaerobic infections: a review of its activity, pharmacokinetics and therapeutic use. | |
| P478 | volume | 16 |
| Q34518691 | A rapid and specific semi-micro method involving high-pressure liquid chromatography for the assay of metronidazole in plasma, saliva, serum, urine and whole blood |
| Q50137378 | Activation of tinidazole, an antiprotozoal drug to a mutagen by mammalian liver S9. |
| Q35716517 | Activity of metronidazole and its hydroxy and acid metabolites against clinical isolates of anaerobic bacteria |
| Q40698572 | Antibiotics for pneumonia therapy |
| Q41912141 | Chloroquine-Induced Acute Dystonic Reactions in the Presence of Metronidazole |
| Q37939570 | Choice of antibiotics, pharmacokinetics, and dose adjustments in acute and chronic renal failure. |
| Q92443220 | Commercial Local Pharmacotherapeutics and Adjunctive Agents for Nonsurgical Treatment of Periodontitis: A Contemporary Review of Clinical Efficacies and Challenges |
| Q39856824 | Comparative penetration of metronidazole, clindamycin, chloramphenicol, cefoxitin, ticarcillin, and moxalactam into bone |
| Q35742386 | Comparative pharmacokinetics of metronidazole and tinidazole as influenced by administration route |
| Q60777254 | Concentrations of metronidazole and tinidazole in female reproductive organs after a single intravenous infusion and after repeated oral administration |
| Q35648033 | Concentrations of metronidazole and tinidazole in male genital tissues |
| Q71468053 | Detection of anaerobic odontogenic infections by fluorine-18 fluoromisonidazole |
| Q71166837 | Disposition and removal of metronidazole in patients undergoing haemodialysis |
| Q44170494 | Disposition kinetics of metronidazole in children |
| Q35127615 | Disposition of intravenous metronidazole in Asian surgical patients |
| Q34495386 | Disposition of oral metronidazole in hepatic cirrhosis and in hepatosplenic schistosomiasis |
| Q41863664 | Disseminated Osteomyelitis Caused by Clostridium novyi in a Cat. |
| Q35674447 | Intravenous metronidazole for treatment of infections involving anaerobic bacteria |
| Q35117165 | Intravenous metronidazole in the newborn |
| Q68916981 | Metronidazole |
| Q70243095 | Metronidazole |
| Q43759461 | Metronidazole pharmacokinetics in patients with hepatic encephalopathy |
| Q33471733 | Metronidazole versus placebo in the treatment of gaseous discomfort in patients having an ileostomy. A double-blind cross-over investigation |
| Q90367067 | Microbial aetiology of brain abscess in a UK cohort: Prominent role of Streptococcus intermedius |
| Q33495982 | New synthesis and antiparasitic activity of model 5-aryl-1-methyl-4-nitroimidazoles |
| Q40167125 | Nitroimidazoles as chemotherapeutic agents |
| Q38780935 | One-step hydrothermal synthesis of photoluminescent carbon nanodots with selective antibacterial activity against Porphyromonas gingivalis |
| Q40145299 | Oral Antimicrobial Drugs |
| Q70290957 | Pharmacokinetics and tissue distribution of metronidazole in the new born infant |
| Q70856442 | Pharmacokinetics of antimicrobial agents |
| Q68313647 | Pharmacokinetics of intravenous metronidazole in neonates |
| Q35757455 | Pharmacokinetics of metronidazole in patients undergoing continuous ambulatory peritoneal dialysis |
| Q34621505 | Placental transfer of metronidazole and tinidazole in early human pregnancy after a single infusion |
| Q40281620 | Potentially synergistic antimicrobial combinations with metronidazole against Bacteroides fragilis |
| Q36427549 | Promotion of the translocation of enteric bacteria from the gastrointestinal tracts of mice by oral treatment with penicillin, clindamycin, or metronidazole. |
| Q34299075 | Quality of use of parenteral metronidazole therapy in a teaching hospital |
| Q43756832 | Quantification of metronidazole in small-volume biological samples using narrow-bore high-performance liquid chromatography |
| Q71012592 | Rectal Administration of Metronidazole Provides Therapeutic Plasma Levels in Postoperative Patients |
| Q37074148 | Relation between concentrations of metronidazole and Bacteroides spp in faeces of patients with Crohn's disease and healthy individuals |
| Q40618580 | Ruthenium(II) Sulfoxide−Maltolato and −Nitroimidazole Complexes: Synthesis and MTT Assay |
| Q36476015 | Serum, saliva, and sputum levels of metronidazole in acute exacerbations of chronic bronchitis |
| Q43991446 | Spectrophotometric determination of metronidazole and tinidazole in pharmaceutical preparations |
| Q39675259 | Symposium on antimicrobial agents. Metronidazole |
| Q36716969 | The penetration of metronidazole into synovial fluid |
| Q34712600 | Tinidazole in anaerobic infections: a review of its antibacterial activity, pharmacological properties and therapeutic efficacy |
| Q66941026 | Treatment of Infections due to Nonsporing Anaerobes |
| Q93681721 | [Drug-induced agranulocytosis. Discussion of the responsibility of metronidazole] |
| Q69406452 | [Effect of metronidazole on the gastrointestinal flora of swine] |
Search more.